Skip to content
zameds

Dequalinium

Schedule 1 to 2, conditions apply
Loading the molecular structure
C30H40N42+456.70 g/mol

1-[10-(4-Amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine

Drag to rotate. Structure from PubChem CID 2993.

Background

Loading...
Loading Wikipedia summary

Listing

Schedules
Schedule 1 to 2, conditions apply
Source
Consolidated Schedules 06 July 2026

Registered medicines

2 registered products listed

Counted through the register's ingredient index, which does not reach every record.

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
DequaliniumFluomizin vaginal, Dequadin antiseptic, Dequacets10mg, oral3 applicants3 registrationsS1 to S2conditions apply
Dequalinium, lidocaineDequadin mouth paint, FlusinlozengesPharmacare limited û woodmead2 registrationsS1 to S4conditions apply

Regulatory status

Where S1 to S2 sits on the scale

Depends on which listing applies

At the least restrictive, Schedule 1: sold by a pharmacist, no doctor's prescription needed. At the most restrictive, Schedule 2: a pharmacist can sell it directly, without a prescription. The listings below say which applies to which form, strength or pack size.

Schedule S1 to S2, as the Consolidated Schedules list it.

Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Dequalinium

  • S2: Dequalinium

    • when intended for human vaginal use;
    • except when intended for oral topical use, as oral solutions or lozenges (S1)

    Consolidated Schedules 06 July 2026, lines 1791 to 1795

  • S1: Dequalinium

    • when intended for oral topical use, as oral solutions or lozenges;
    • except when intended for human vaginal use. (S2)

    Consolidated Schedules 06 July 2026, lines 359 to 363

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Research articles

Loading...
Loading PubMed articles